The Top 35 Countries by Antibiotic Use—See Where the U.S. Ranks
This was originally posted on our Voronoi app. Download the app for free on iOS or Android and discover incredible data-driven charts from a variety of trusted sources.
Key Takeaways
- Iran tops the list of antibiotic use at 68 defined daily doses (DDD) per 1,000 people.
- The U.S. ranks 23rd, with 22 DDD per 1,000 inhabitants, below many European peers.
Antibiotics revolutionized medicine, but overuse accelerates drug-resistant “superbugs.”
This ranking shows the countries with the most antibiotic use, measured by defined daily doses (DDD) per 1,000 people.
DDD: A typical adult’s one-day treatment (for the drug’s main use).Data for this visualization comes from Our World in Data and the One Health Trust as of 2022. Figures are rounded.
Skip to the second-last section for more information about how this data was collected.
Iran and Emerging Economies Lead Antibiotic Consumption
Iran’s 68 DDD per 1,000 people is more than triple the global median (18 DDD), reflecting looser prescription controls and ease of over-the-counter access.
| Rank | Country | Daily dose of antibiotics (DDD), used per 1,000 inhabitants, 2022 |
|---|---|---|
| 1 | Iran |
68 |
| 2 | South Africa |
51 |
| 3 | Egypt |
50 |
| 4 | Bangladesh |
49 |
| 5 | Tanzania |
35 |
| 6 | Jordan |
34 |
| 7 | Cyprus |
34 |
| 8 | Montenegro |
33 |
| 9 | Nepal |
32 |
| 10 | Laos |
30 |
| 11 | Romania |
29 |
| 12 | Tunisia |
28 |
| 13 | France |
25 |
| 14 | Malta |
25 |
| 15 | Poland |
24 |
| 16 | Italy |
24 |
| 17 | Spain |
24 |
| 18 | Uganda |
23 |
| 19 | Benin |
23 |
| 20 | Ireland |
23 |
| 21 | Kuwait |
23 |
| 22 | Palestine |
23 |
| 23 | U.S.* |
22 |
| 24 | Maldives |
21 |
| 25 | Belgium |
21 |
| 26 | Georgia |
20 |
| 27 | Croatia |
20 |
| 28 | Côte d’Ivoire |
20 |
| 29 | UK |
20 |
| 30 | Lithuania |
20 |
| 31 | Iceland |
19 |
| 32 | Portugal |
18 |
| 33 | Colombia |
18 |
| 34 | Czechia |
18 |
| 35 | Tajikistan |
17 |
| 36 | Belarus |
17 |
| 37 | Russia |
17 |
| 38 | Latvia |
16 |
| 39 | Denmark |
15 |
| 40 | Canada |
15 |
| 41 | Hungary |
15 |
| 42 | Hong Kong |
14 |
| 43 | Papua New Guinea |
14 |
| 44 | Estonia |
13 |
| 45 | Bhutan |
13 |
| 46 | Slovenia |
13 |
| 47 | Finland |
12 |
| 48 | Norway |
12 |
| 49 | Malaysia |
11 |
| 50 | Ethiopia |
11 |
| 51 | Austria |
11 |
| 52 | Ukraine |
11 |
| 53 | Switzerland |
11 |
| 54 | Saudi Arabia |
11 |
| 55 | Germany |
10 |
| 56 | Armenia |
10 |
| 57 | Peru |
10 |
| 58 | Rwanda |
9 |
| 59 | Mali |
8 |
| 60 | Qatar |
7 |
| 61 | Oman |
6 |
*Separate source: One Health Trust.
A recent study found that nearly half of outpatient antibiotic prescriptions in Iran “lacked medical justification.”
Iran is not the only middle-income country with a high antibiotic use.
South Africa (51 DDD) and Egypt (50 DDD) follow close behind.
Even poorer economies such as Bangladesh and Tanzania post rates above 35 DDD, outstripping any EU member.
High DDDs can indicate that a country either faces a heavy disease burden or is experiencing over-prescription and misuse.
Misuse is most common in low- and middle-income countries, where health care access is limited. Weak enforcement of sales rules lets pharmacies and informal sellers dispense antibiotics freely.
Europe Shows a Wide Spread in Antibiotic Use
Within Europe, southern nations use far more antibiotics than their northern neighbors.
France, Malta, Italy, and Spain all hover around 24–25 DDD.
Meanwhile Nordic countries like Denmark, Norway, and Finland sit near or below 15 DDD (not in the graphic but listed in the table above.)
Cultural attitudes toward prescribing, national action plans, and availability of narrow-spectrum alternatives all influence these disparities.
U.S. Antibiotic Use
At 22 DDD, the U.S. places 23rd out of the 35 countries shown, higher than Canada (15 DDD) and the U.K. (20 DDD), yet lower than much of Southern Europe.
This figure is from One Health Trust as the primary source did not list a comparative U.S. figure. Studies show outpatient prescriptions have fallen 13% between 2011–2019, thanks to campaigns that target inappropriate treatment of viral infections.
Still, about one in three American prescriptions is considered unnecessary, suggesting considerable room to close the gap with low-use peers like Germany (10 DDD per 1,000 people).
Related: The U.S. could be short 90,000 primary care physicians by 2037. See how many doctors are available per capita by state right now.How Do Sources Track Antibiotic Use?
Our World in Data is the primary source for this graphic and article. It processes figures from the WHO’s GLASS platform, which countries feed with standardized data so researchers can compare antimicrobial consumption across regions.
Participating countries report national antimicrobial use from sources like insurance claims, import records, and hospital prescriptions, including antituberculosis drugs. GLASS enforces a common methodology to ensure consistency.
The One Health Trust draws on the IQVIA MIDAS database to estimate national antibiotic consumption from retail and hospital pharmacy sales.
It samples manufacturer and wholesaler sales across distribution channels and scales them to national totals using a proprietary algorithm that applies regional, sector-specific, and channel-specific factors.
The exact algorithm remains undisclosed.
Learn More on the Voronoi App 
If you enjoyed today’s post, check out Ranked: America’s Most Popular Drugs by Dollars Spent on Voronoi, the new app from Visual Capitalist.



Iran
South Africa
Egypt
Bangladesh
Tanzania
Jordan
Cyprus
Montenegro
Nepal
Laos
Romania
Tunisia
France
Malta
Poland
Italy
Spain
Uganda
Benin
Ireland
Kuwait
Palestine
U.S.*
Maldives
Belgium
Georgia
Croatia
Côte d’Ivoire
UK
Lithuania
Iceland
Portugal
Colombia
Czechia
Tajikistan
Belarus
Russia
Latvia
Denmark
Canada
Hungary
Hong Kong
Papua New Guinea
Estonia
Bhutan
Slovenia
Finland
Norway
Malaysia
Ethiopia
Austria
Ukraine
Switzerland
Saudi Arabia
Germany
Armenia
Peru
Rwanda
Mali
Qatar
Oman












